ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,387,306 | -58.8% | 1,131,775 | -53.0% | 0.44% | -54.0% |
| Q4 2022 | $47,107,906 | +40.1% | 2,407,149 | +14.2% | 0.96% | +33.2% |
| Q3 2022 | $33,630,000 | +16.0% | 2,107,149 | 0.0% | 0.72% | -7.2% |
| Q2 2022 | $28,994,000 | -13.2% | 2,107,149 | 0.0% | 0.77% | +6.0% |
| Q1 2022 | $33,419,000 | -27.3% | 2,107,149 | 0.0% | 0.73% | -10.1% |
| Q4 2021 | $45,999,000 | -27.0% | 2,107,149 | 0.0% | 0.81% | -7.1% |
| Q3 2021 | $62,983,000 | -32.5% | 2,107,149 | 0.0% | 0.87% | -41.7% |
| Q2 2021 | $93,326,000 | -0.2% | 2,107,149 | 0.0% | 1.50% | +6.2% |
| Q1 2021 | $93,494,000 | -20.2% | 2,107,149 | -1.4% | 1.41% | -13.9% |
| Q4 2020 | $117,143,000 | – | 2,136,081 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |